Worldwide News

Property provider Bruntwood SciTech, dedicated to the growth of the science and technological sector, has expanded into the “Golden Triangle” through the acquisition of Melbourn Science Park from independent technology and product development company TTP for £46.2 million. Bruntwood SciTech will work closely with the local planning authority to develop the site; expanding its national […]

The latest DDW Sitting Down With podcast features Guy Goldberg, Chief Business Officer of RedHill Biopharma. RedHill Biopharma  is a biopharmaceutical company that recently announced the dosing of the first patient in its US Phase II/III study of orally-administered RHB-107 (upamostat), an investigational new drug for patients with symptomatic COVID-19 who do not require hospital […]

WuXi AppTec, provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, has completed the acquisition of OXGENE, a UK-based contract research and development organisation that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cell […]

Phesi, provider of AI-based clinical development analytics products and solutions, is showcasing its data-driven clinical development approach at SCOPE Virtual Summit for Clinical Operations Executives 2021, in a case study session with international pharmaceutical company, Alfasigma. Phesi and Alfasigma are currently working together to maximise the value of priority medical assets, explore the use of […]

ILC Therapeutics, a biotech company based in Scotland, is developing a synthetic Interferon which has shown great promise against COVID-19 in laboratory testing and will enter clinical trials later this year. It will be, says the company, the first synthetic Interferon based on the most prominent activities of the natural Interferons. The company believes that […]

ChromoTek, part of Proteintech specialising in nanobody-based reagents, and Absolute Antibody, provider of recombinant antibody technology, have announced a partnership to offer recombinant engineered antibodies to scientists worldwide. The chimeric antibodies were originally derived from alpaca nanobodies and engineered onto mouse and rabbit Fc domains to open up new research applications. Available antibodies target key […]

by Tiago R. Felix Simply put, drugs alone are not, and will probably not be, an effective and safe treatment for most cases of nervous system disorders (NSDs). However, both society and the pharmaceutical industry seem to have so far largely overlooked the most promising alternative to drugs in the treatment of NSDs, that is, […]

Last year IONTAS, a biotechnology company focused on antibody discovery and development, entered into a licensing agreement with Bristol Myers Squibb for its proprietary mammalian display. John McCafferty, nuclease directed mammalian display inventor and co-inventor of antibody phage display, told Lu Rahman about this breakthrough work. The company operates as a single group comprised of […]

SLAS Europe 2021 Hybrid will take place on 22-25 June in Vienna and online. The event will include short courses which will take place on 22 June, followed by a two-day exhibition on 23-24 June. There will also be three days of scientific sessions from 23-25 June. Other features include tutorials, networking, demonstrations and giveaways, […]

Waters Corporation has entered a reseller agreement with TetraScience, a cloud technology innovator for life sciences R&D. Through the partnership, Waters will offer its customers the Empower Data Science Link, powered by TetraScience. This technology pairs Waters’ compliance-ready Empower Chromatography Data System (CDS) with TetraScience’s Data Platform and data science tools, providing insights into chromatography […]